1. Home
  2. PLBY vs EMBC Comparison

PLBY vs EMBC Comparison

Compare PLBY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

HOLD

Current Price

$1.26

Market Cap

204.4M

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.59

Market Cap

199.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBY
EMBC
Founded
1953
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.4M
199.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PLBY
EMBC
Price
$1.26
$3.59
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$18.50
AVG Volume (30 Days)
732.9K
1.4M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
87.50
20.90
EPS
N/A
0.67
Revenue
$120,928,000.00
N/A
Revenue This Year
$9.17
$1.17
Revenue Next Year
$7.10
N/A
P/E Ratio
N/A
$5.13
Revenue Growth
4.13
N/A
52 Week Low
$1.08
$2.77
52 Week High
$2.75
$15.55

Technical Indicators

Market Signals
Indicator
PLBY
EMBC
Relative Strength Index (RSI) 49.26 57.83
Support Level $1.23 $3.03
Resistance Level $1.94 $9.45
Average True Range (ATR) 0.07 0.14
MACD 0.02 0.06
Stochastic Oscillator 77.14 93.64

Price Performance

Historical Comparison
PLBY
EMBC

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: